Valneva SE (VALN)
Valneva SE, a specialty vaccine company, develops, manufactures, and commercializes prophylactic vaccines for infectious diseases with unmet needs. It offers IX...
- Open
- 6.640
- High
- 6.640
- Low
- 6.480
- Prev. Close
- 6.670
- Volume
- 23.79K
- Turnover
- 155.95K
- Avg Price
- 6.555
- Bid/Ask Ratio
- --
- Amplitude
- 2.40%
- 52wk High
- 12.230
- Volume Ratio
- 2.91
- Turnover Ratio
- 0.03%
Valneva SE Analyst Rating
View moreForecast & Rating
Aug 14, 2026Price forecast
$12.2587.02%
Forecast & RatingBuy
4analysts
- Strong buy75.00%
- Buy0.00%
- Hold0.00%
- Sell25.00%
- Strong sell0.00%
News
- PUBT · 1 day ago, 01:39 PM
PDT Partners discloses net short position in Valneva shares
- PUBT · Sep 4 at 04:00 PM
Valneva reports 189,771,237 issued shares, 204,364,085 total voting rights as of Aug. 31, 2026
- PUBT · Sep 3 at 02:12 PM
Citadel Advisors discloses net short position in Valneva shares
- PUBT · Aug 28 at 01:40 PM
Citadel Advisors discloses net short position in Valneva
- Market Beat · Aug 25 at 10:14 AM
Valneva SE Sponsored ADR (NASDAQ:VALN) Given Consensus Recommendation of "Hold" by Analysts
